Status:
COMPLETED
Insulin Therapy in the Hospital Comparing Two Protocols
Lead Sponsor:
Cook County Health
Collaborating Sponsors:
Eli Lilly and Company
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine if by using insulin analog (Glargine and lispro insulin) with an insulin pen the investigators are able to obtain a higher rate of correct timing of insulin a...
Eligibility Criteria
Inclusion
- Uncontrolled blood sugar:
- Random blood sugar ≥ 200mg/dl
- Pre-prandial blood sugar greater than 180 mg/dl on two occasions within 24 hours.
- Patient may be off insulin or on subcutaneous inpatient insulin regimen less than 36 hours.
- Transition from an Insulin Drip in the intensive care units to subcutaneous insulin upon transfer to general ward.
- Patient is able to eat and oral feeding is expected.
Exclusion
- Patients receiving inpatient oral hypoglycemic agents
- Patients with chronic kidney disease stages 4 \& 5 (estimated GFR of \<30ml/min) and on dialysis
- Patient with chronic liver disease
- Patient with hypoglycemia unawareness
- Pregnancy
- Patients who are on "NPO" for medical reasons.
- Patient is expected to stay in the hospital for less than 3 days.
- Patient on a new inpatient insulin regimen for \> 36 hours.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00841919
Start Date
December 1 2006
End Date
June 1 2009
Last Update
September 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
John H Stroger Jr. Hospital
Chicago, Illinois, United States, 60612